WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong
· Delayed Price · Currency is HKD 23.50
-0.20 (-0.84%)
May 28, 2025, 10:45 AM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 96.34 billion as of May 27, 2025. Its market cap has increased by 65.78% in one year.
Market Cap
96.34B
Enterprise Value
94.09B
Revenue
19.87B
Ranking
n/a
PE Ratio
28.38
Stock Price
23.50
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 96.34B, an increase of 200.70%. That is a compound annual growth rate of 14.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 223.86B |
| Hansoh Pharmaceutical Group Company | 152.51B |
| JD Health International | 131.76B |
| Innovent Biologics | 96.66B |
| CSPC Pharmaceutical Group | 75.66B |
| Sino Biopharmaceutical | 74.80B |
| Akeso | 74.63B |
| Alibaba Health Information Technology | 72.37B |